Eloxx Pharmaceuticals, Inc. - Common Stock (NQ:ELOX)

17.00 -0.57 (-3.24%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 10, 2026 Add to My Watchlist

Price and Volume

Volume	62,609
Open	16.80
Bid (Size)	16.55 (200)
Ask (Size)	24.50 (100)
Prev. Close	17.57
Today's Range	16.80 - 18.48
52wk Range	8.200 - 19.36
Shares Outstanding	2,752,774
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates

April 16, 2024

From Eloxx Pharmaceuticals

Via GlobeNewswire

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases

March 13, 2024

From Eloxx Pharmaceuticals

Via GlobeNewswire

Performance

YTD	+54.4%	+54.4%
1 Month	+43.9%	+43.9%
3 Month	+54.4%	+54.4%
6 Month	+54.4%	+54.4%
1 Year	+54.4%	+54.4%

More News

Off the Beaten Path: 3 Delisted Stocks for The Speculative Investor ↗

December 05, 2023

Via InvestorPlace

Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update

November 13, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Eloxx Pharmaceuticals Inc. (NASDAQ: ELOX) Near the Top of Equities by Percentage Gain on 8/30

August 30, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 13, 2023

Via Benzinga

Eloxx Pharmaceuticals Reports Additional Confirmation that All Nonsense Mutation Alport Syndrome Patients Treated with ELX-02 in Phase 2 Study had Improvement in Kidney Morphology and Clinical Benefit of Reduction or Stabilization of Proteinuria

October 09, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Eloxx Pharmaceuticals Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

September 19, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Eloxx Pharmaceuticals Reports Independent Confirmation of Positive Biopsy Results in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome

September 18, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 14, 2023

Via Benzinga

Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013

September 07, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 15, 2023

Via Benzinga

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 14, 2023

Via Benzinga

Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update

August 14, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Why US Steel Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket ↗

August 14, 2023

Via Benzinga

Eloxx Pharmaceuticals Reports Drug Response in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome

August 14, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement

August 03, 2023

From Eloxx Pharmaceuticals

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 13, 2023

Via Benzinga

Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 13, 2023

Via Benzinga

Why Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

July 13, 2023

Via Benzinga

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Via Benzinga

This Small Cap Stock Surged Over 100%

July 12, 2023

Via MarketBeat

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 12, 2023

Via Benzinga

Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 12, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 12, 2023

Via InvestorPlace

Frequently Asked Questions

Is Eloxx Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Eloxx Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Eloxx Pharmaceuticals, Inc. - Common Stock trade on?

Eloxx Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Eloxx Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Eloxx Pharmaceuticals, Inc. - Common Stock is ELOX on the Nasdaq Stock Market

What is the current price of Eloxx Pharmaceuticals, Inc. - Common Stock?

The current price of Eloxx Pharmaceuticals, Inc. - Common Stock is 17.00

When was Eloxx Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Eloxx Pharmaceuticals, Inc. - Common Stock was at 08/10/26 04:00 PM ET

What is the market capitalization of Eloxx Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Eloxx Pharmaceuticals, Inc. - Common Stock is 46.80M

How many shares of Eloxx Pharmaceuticals, Inc. - Common Stock are outstanding?

Eloxx Pharmaceuticals, Inc. - Common Stock has 47M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.